Home › Therapeutic areas › Renal › Lupus Nephritis
Lupus Nephritis (9 companies)
Companies with an active program in Lupus Nephritis.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics | HematologyOphthalmology+2 Rare | 1 | Approved | 10 |
| ANNX | Annexon | HematologyNeurology+2 Rare | 1 | NDA Submitted | 6 |
| ARTV | Artiva Biotherapeutics | DermatologyImmunology+2 Rare | 1 | Phase 2 | 16 |
| AUTL | Autolus Therapeutics | HematologyImmunology+3 Rare | 1 | Approved | 12 |
| CABA | Cabaletta Bio | DermatologyImmunology+2 Rare | 1 | Phase 1 | 8 |
| IPSC | Century Therapeutics | ImmunologyMetabolic+1 Rare | 2 | Phase 1 | 11 |
| CGEM | Cullinan Therapeutics | HematologyImmunology+2 Rare | 1 | NDA Submitted | 10 |
| KYTX | Kyverna Therapeutics | ImmunologyNeurology+1 Rare | 1 | NDA Submitted | 7 |
| NKTX | Nkarta | ImmunologyNeurology+1 Rare | 1 | Phase 1 | 7 |
No companies match.